Israeli startup uses AI to find best depression treatment
Predictix by Taliaz aims to help psychiatrists match each patient with the most effective prescription.
Press-center
All company news and stories
Israeli app becomes world’s largest cancer social network
Belong life for cancer patients and caregivers uses artificial intelligence to cut through data clutter. Users only see the most relevant information.
Breakthrough in understanding of immune system dysfunction
Israeli and international scientists pinpoint protein that regulates exhaustion in T cells in discovery that may help fight disease.
Pluristem gets positive results from radiation treatment trials
TEL AVIV - Israel’s Pluristem Therapeutics Inc reported on Wednesday positive results from a series of studies in animals of its placenta-based stem cell therapy to treat acute radiation syndrome (ARS).
Israeli startup develops blood pump to help treat heart failure
Magenta Medical, an Israeli developer of a miniaturized blood pump to help treat heart failure, has raised funds from investors led by venture capital firm New Enterprise Associates (NEA), a US-based VC firm.
Israeli researchers discover how to boost Natural cancer-kiling cells
The future of cancer treatments rests also on the shoulders of Natural Killer cells, according to a recent study conducted by Israeli Professor Angel Porgador, of the Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University, and the National Institute of Biotechnology in the Negev (NIBN).
Israeli researchers develop MRI technique to detect molecular changes in brain
Math model developed by Hebrew University team could pave the way for physicians to see beginnings of Alzheimer’s or Parkinson’s.
Israel researchers develop algorithm that may help predict onset of tuberculosis
Weizmann Institute team says early interactions between immune cells and bacteria determine the outcome of illnesses.
A vaccine for skin cancer? Tel Aviv researchers say they have developed one
Tel Aviv University (TAU) researchers say they have developed a novel nano-vaccine for melanoma, the most aggressive type of skin cancer.
New products
All products
